Bővebb ismertető
European Journal of Pharmacology, 175 (1990) v-xi Elsevier
Notice to authors
1. General
1.1. Manuscripts
The original and 2 copies, complete with 3 sets of figures and tables should be sent to:
The editorial office of the European Journal of Pharmacology, P.O. Box 5023, 3502 JA Utrecht, or: Vondellaan 6, 3521 GD Utrecht, The Netherlands; tel. 31 (30) 884685. Manuscripts should be typewritten with double spacing and with wide margins (not more than 26 hnes per page). Manuscripts should be written in Enghsh. The manuscripts will, if necessary, be corrected for English style and language. Such correction will be carried out by a qualified pharmacologist and is final.
1.2. Typing
Webster's New International Dictionary or the Oxford English Dictionary should be consulted for spelling. Latin plurals should not be used if the English equivalent has become the accepted form, e.g. formulas not formulae. Use of hyphens, capital letters, numbers written or spelled out (e.g. 8 or eight) should be consistent throughout the manuscript. Words at the end of a Une should not be divided.
1.3. Abbreviations
The number of abbreviations used should be kept to an absolute minimum. Any abbreviations used should be used with consistency. Abbreviations should be avoided in the title and the abstract. If abbreviations are used in the abstract, they should be defined in the abstract as well as in the body of the manuscript. The generally accepted abbreviations, but not ad hoc abbreviations, should
be used for chemical compounds. Non-proprietary names (generic names) should not be abbreviated. As an example, HAL, TAM for haloperidol, tamoxifen are NOT acceptable. Unwieldy chemical names may be abbreviated or code names may be used. The full chemical name should be given once in the body of the manuscript and in the abstract if needed, followed in both cases by the code name or the abbreviation (in parentheses).
Some abbreviations may be used without definition:
ADP, CDF 5'-pyrophosphates of adeno-GDP, IDF, sine, cytidine, guanosine, UDF inosine, uridine
AMF etc. adenosine 5'-phosphate etc.
ATF etc. adenosine 5'-triphosphate etc.
CM-cellulose carboxymethylceUulose CoA and coenzyme A and its acyl deriva-
acetyl-CoA tives
DEAE- diethylaminoethylcellulose
cellulose
DNA deoxyribonucleic acid
DNF- 2,4-dinitrophenyl-
EDTA ethylenediaminetetra-acetate
EGTA ethyleneglycol-bis-(;8-amino-
ethylether)N,N,N',N'-tetra-acetate FAD flavin-adenine dinucleotide
FMN flavin mononucleotide
GSH, GSSG glutathione, reduced and oxidized
HEPES 4-(2-hydroxyethyl)-l-pipera-
zine-ethanesulphonic acid NAD nicotinamide-adenine dinucleo-
tide
NADF nicotinamide-adenine dinucleo-
tide phosphate NMN nicotinamide mononucleotide
0014-2999/90/$03.50 © 1990 Elsevier Science Publishers B.V. (Biomedical Division)